ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr | ₹271 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹92 Cr |
Mar2023 | ₹285 Cr |
Mar2022 | ₹269 Cr |
Mar2021 | ₹292 Cr |
Mar2020 | ₹271 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹92 Cr | -67.77 | |
Mar2023 | ₹285 Cr | 5.93 | |
Mar2022 | ₹269 Cr | -7.89 | |
Mar2021 | ₹292 Cr | 7.67 | |
Mar2020 | ₹271 Cr | - |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹57,894.2 Cr | 0.9% | -0.2% | -8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 0.9% |
-0.2% |
-8% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses